Atropine/chlorphenamine/pseudoephedrine - MAGNA Pharmaceuticals

Drug Profile

Atropine/chlorphenamine/pseudoephedrine - MAGNA Pharmaceuticals

Alternative Names: Atr/CM/PSE - Magna Pharmaceuticals; Atropine/chlorpheniramine/pseudoephedrine - MAGNA Pharmaceuticals; Atropine/pseudoephedrine/chlorphenamine - MAGNA Pharmaceuticals; Chlorphenamine/atropine/pseudoephedrine - MAGNA Pharmaceuticals; Chlorphenamine/pseudoephedrine/atropine - MAGNA Pharmaceuticals; Chlorpheniramine/pseudoephedrine/atropine - MAGNA Pharmaceuticals; Pseudoephedrine/atropine/chlorphenamine - MAGNA Pharmaceuticals; Pseudoephedrine/chlorphenamine/atropine - MAGNA Pharmaceuticals; StahistRx

Latest Information Update: 21 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator MAGNA Pharmaceuticals
  • Class Alkaloids; Antiallergics; Antihistamines; Decongestants; Propanolamines; Pyridines; Small molecules; Tropanes
  • Mechanism of Action Alpha adrenergic receptor agonists; Cholinergic receptor antagonists; Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Seasonal allergic rhinitis

Most Recent Events

  • 21 Jun 2016 No recent reports on development identified - Phase-II for Seasonal allergic rhinitis (In adolescents and adults) in USA (PO)
  • 29 May 2014 MAGNA Pharmaceuticals completes enrolment in its phase II trial for Seasonal allergic rhinitis (In adolescents and adults) in USA (NCT02082054)
  • 31 Mar 2014 Phase-II clinical trials in Seasonal allergic rhinitis (In adolescents and adults) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top